Sputnik V Vaccine Launches Social Media Campaigns

Moscow-based Russian Direct Investment Fund (RDIF) and the N.F. The Gamaleis, a research center, announced the launch of an international social media campaign that will offer information on the Sputnik V vaccine candidate. This media campaign uses the #SputnikV hashtag.

Late-stage clinical trials of Sputnik V are currently being conducted in the Russian Federation, the Republic of Belarus, the United Arab Emirates, India, and Brazil.

The RDIF stated it has sent a request to the WHO for accelerated registration and prequalification of the Sputnik V vaccine.